It proposed a clinical response to Clopidogrel, an oral, thienopyridine-class antiplatelet agent
used to inhibit blood clots in coronary artery disease.
Daiichi Sankyo Company, Limited today announced that it has launched the antiplatelet agent
Just as Sanofi-Aventis lost exclusivity for its blockbuster drug Plavix (clopidogrel), the Food and Drug Administration approved several generic formulations of the antiplatelet agent
I started to work with the antiplatelet agent
abciximab, an intravenous glycoprotein 2b/3a antagonist.
1) Aspirin, a salicylate, is the most commonly used over-the-counter (OTC) antiplatelet agent
, taken at either an 81 mg dose for cardioprevention or a full-strength dose of 325 mg.
There are no clinical trials demonstrating that changing from one antiplatelet agent
to another, or increasing the dose, following a TIA or stroke is beneficial in reducing recurrence.
26] However, clopidogrel is the main antiplatelet agent
associated with drug-eluting stent thrombosis when withdrawn.
One investigation that would assist in the management of these patients is an accurate contemporaneous assessment of the effect of the antiplatelet agent
on their platelet function.
5% of residents with a history of stroke were not receiving an anticoagulant or antiplatelet agent
and 21 other companies manufacturing the antiplatelet agent
about its adverse side effects and instructed them to add a warning on documents accompanying the product, ministry officials said.
announced that it has received approval from the Ministry of Health, Labor and Welfare in Japan for the antiplatelet agent
On Thursday, February 13, 2014, Medicines announced that the FDA Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against approval of the intravenous antiplatelet agent
Cangrelor for use in patients undergoing percutaneous coronary intervention (PCI) -- or cardiac stent procedures -- or those that require bridging from oral antiplatelet therapy to surgery.